Business Description
BBS-Bioactive Bone Substitutes PLC
ISIN : FI4000260583
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.42 | |||||
Equity-to-Asset | 0.48 | |||||
Debt-to-Equity | 0.93 | |||||
Debt-to-EBITDA | -1.51 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 12.3 | |||||
3-Year EPS without NRI Growth Rate | 12.6 | |||||
3-Year FCF Growth Rate | 15.3 | |||||
3-Year Book Growth Rate | -28.4 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 5.48 | |||||
9-Day RSI | 11.95 | |||||
14-Day RSI | 18.88 | |||||
6-1 Month Momentum % | -9.92 | |||||
12-1 Month Momentum % | -32.87 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.47 | |||||
Quick Ratio | 1.47 | |||||
Cash Ratio | 1.43 | |||||
Days Payable | 14006.88 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -31.9 | |||||
Shareholder Yield % | -39.12 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -76.08 | |||||
ROA % | -32.63 | |||||
ROIC % | -32.79 | |||||
ROC (Joel Greenblatt) % | -309.85 | |||||
ROCE % | -37.68 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.52 | |||||
EV-to-EBIT | -2.74 | |||||
EV-to-EBITDA | -2.92 | |||||
EV-to-FCF | -3.88 | |||||
Earnings Yield (Greenblatt) % | -36.53 | |||||
FCF Yield % | -45.46 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
BBS-Bioactive Bone Substitutes PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.257 | ||
Beta | 0.75 | ||
Volatility % | 81.39 | ||
14-Day RSI | 18.88 | ||
14-Day ATR (€) | 0.033492 | ||
20-Day SMA (€) | 0.4646 | ||
12-1 Month Momentum % | -32.87 | ||
52-Week Range (€) | 0.319 - 0.919585 | ||
Shares Outstanding (Mil) | 18.37 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
BBS-Bioactive Bone Substitutes PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
BBS-Bioactive Bone Substitutes PLC Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
BBS-Bioactive Bone Substitutes PLC Frequently Asked Questions
What is BBS-Bioactive Bone Substitutes PLC(OHEL:BONEH)'s stock price today?
When is next earnings date of BBS-Bioactive Bone Substitutes PLC(OHEL:BONEH)?
Does BBS-Bioactive Bone Substitutes PLC(OHEL:BONEH) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |